BAILLIE GIFFORD & CO - 31 Dec 2024 SCHEDULE 13G/A Report for Denali Therapeutics Inc. Common Stock (DNLI)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: Denali Therapeutics Inc. Common Stock
Symbol: DNLI
Shares outstanding: 143,185,244 shares
Disclosed Ownership: 12,313,931 shares
Ownership: 8.6%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 10:52:00 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	8.6%	12,313,931	12,239,731		Grant Meikle	Threshold & Transaction Manager